EWA
AGIO icon

Exencial Wealth Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Exencial Wealth Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-40,322
Closed -$1.86M – 473
2021
Q3 		$1.86M Hold
40,322
– – 0.08% 155
2021
Q2 		$2.22M Hold
40,322
– – 0.12% 174
2021
Q1 		$2.08M Hold
40,322
– – 0.12% 168
2020
Q4 		$1.75M Hold
40,322
– – 0.12% 162
2020
Q3 		$1.41M Hold
40,322
– – 0.07% 183
2020
Q2 		$2.16M Hold
40,322
– – 0.19% 135
2020
Q1 		$1.43M Sell
40,322
-2,076
-5% -$95.9K 0.26% 94
2019
Q4 		$2.02M Buy
+42,398
New +$1.6M 0.35% 85

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Exencial Wealth Advisors's AGIO Position: Q4 2021 in Review

Exencial Wealth Advisors sold out of Agios Pharmaceuticals (AGIO) in Q4 2021, closing a stake of 40,322 shares — an estimated $1.86M sold.

Exencial Wealth Advisors first reported a position in AGIO in Q4 2019 and held it in 8 quarters. The position peaked at $2.22M in Q2 2021. 161 funds tracked by Wall St. Rank hold AGIO as of Q4 2021.

  • Exencial Wealth Advisors reported no remaining Agios Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Exencial Wealth Advisors sold 40,322 Agios Pharmaceuticals shares in Q4 2021, an estimated $1.86M.
  • Exencial Wealth Advisors first reported a position in Agios Pharmaceuticals in Q4 2019 and held it in 8 quarters.
  • Exencial Wealth Advisors's Agios Pharmaceuticals position peaked at $2.22M in Q2 2021.
  • 161 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2021.

Based on Exencial Wealth Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.